Jixian Liu

1120 Lianhua Road
Shenzhen, 518035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Predictive Value of Circulating Tumor Cells in Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

Predictive Value of Circulating Tumor Cells in Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

Journal: Thoracic cancer

Published: March 05, 2026

Artificial intelligence-assisted proteomic signatures for discriminating malignant from benign pulmonary nodules.

Artificial intelligence-assisted proteomic signatures for discriminating malignant from benign pulmonary nodules.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: February 15, 2026

Transcervical video-assisted mediastinoscopy for resection of an ectopic parathyroid adenoma in the mediastinum: a case report.

Transcervical video-assisted mediastinoscopy for resection of an ectopic parathyroid adenoma in the mediastinum: a case report.

Journal: Frontiers in surgery

Published: February 03, 2026

Development and validation of an immune-related gene set (IRGS) model for prognostic and immunotherapeutic assessment in lung adenocarcinoma (LUAD).

Development and validation of an immune-related gene set (IRGS) model for prognostic and immunotherapeutic assessment in lung adenocarcinoma (LUAD).

Journal: Journal of thoracic disease

Published: August 06, 2025

Large-Scale T-cell Receptor Repertoire Profiling Unveils Tumor-Specific Signals for Diagnosing Indeterminate Pulmonary Nodules.

Large-Scale T-cell Receptor Repertoire Profiling Unveils Tumor-Specific Signals for Diagnosing Indeterminate Pulmonary Nodules.

Journal: Cancer research

Published: March 29, 2025

YY1-Upregulated MTHFD2 Drives Non-Small Cell Lung Cancer Progression Through the Regulation of LRRK2.

YY1-Upregulated MTHFD2 Drives Non-Small Cell Lung Cancer Progression Through the Regulation of LRRK2.

Journal: Journal of biochemical and molecular toxicology

Published: March 17, 2025

Biomarkers for primary graft dysfunction after lung transplantation: a review of current evidence and future prospects.

Biomarkers for primary graft dysfunction after lung transplantation: a review of current evidence and future prospects.

Journal: Frontiers in physiology

Published: January 08, 2025

Transcriptome profiling of tumor-infiltrating lymphocyte-mediated cytotoxicity against patient-derived lung cancer organoids.

Transcriptome profiling of tumor-infiltrating lymphocyte-mediated cytotoxicity against patient-derived lung cancer organoids.

Journal: Communications biology

Published: December 11, 2024

Corrigendum to "Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma" [ Int. Immunopharmacol. 143 (2024) 113282].

Corrigendum to "Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma" [ Int. Immunopharmacol. 143 (2024) 113282].

Journal: International immunopharmacology

Published: November 23, 2024

LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression.

LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression.

Journal: Journal of immunology research

Published: September 29, 2024

CALML3-AS1 enhances malignancies and stemness of small cell lung cancer cells through interacting with DAXX protein and promoting GLUT4-mediated aerobic glycolysis.

CALML3-AS1 enhances malignancies and stemness of small cell lung cancer cells through interacting with DAXX protein and promoting GLUT4-mediated aerobic glycolysis.

Journal: Toxicology and applied pharmacology

Published: September 13, 2024

Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma.

Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma.

Journal: International immunopharmacology

Published: July 27, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026